# Atomoxetine Treatment of Adults With ADHD and Comorbid Alcohol Abuse

> **NCT00190957** · PHASE4 · COMPLETED · sponsor: **Eli Lilly and Company** · enrollment: 140 (—)

## Conditions studied

- ADHD
- Comorbid Alcohol Abuse

## Interventions

- **DRUG:** Atomoxetine
- **DRUG:** placebo

## Key facts

- **NCT ID:** NCT00190957
- **Lead sponsor:** Eli Lilly and Company
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2004-08
- **Primary completion:** —
- **Final completion:** 2006-01
- **Target enrollment:** 140 (—)
- **Last updated:** 2007-11-06


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00190957

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00190957, "Atomoxetine Treatment of Adults With ADHD and Comorbid Alcohol Abuse". Retrieved via AI Analytics 2026-06-23 from https://api.ai-analytics.org/clinical/NCT00190957. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*